Post ASH Significant Highlights
Wednesday 27th January 2021
Virtual Event

This meeting will provide an overview of the most innovative scientific and clinical data presented at the December 2020 ASH virtual meeting which is useful for a UK audience

Aim: The meeting will provide an overview of the most innovative scientific and clinical data presented at the December 2020 ASH virtual meeting, that is useful for a UK audience. Suggested audience: Consultants, trainees, nurses and pharmacists working in haematology

Link for the meeting website - https://hartleytaylor.co.uk/ashc-home/

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator

calculator

Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here